Anifrolumab (Saphnelo) 

March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024.

For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Nuvaxovid in Canada: How to Access the COVID-19 Vaccine

Read

Oral Ulcers and Lupus: More Than a Mouth Sore | Lupus Canada

Read

Lupus and Heart Health: Understanding Cardiovascular Risk in SLE

Read